Provigil Cost in Virginia 2026: Prices, Insurance, Medicaid, and Savings

What Provigil and Generic Modafinil Actually Cost in Virginia

Brand-name Provigil, manufactured by Cephalon (now a Teva subsidiary), carries a manufacturer list price near $850 per month for a 30-day supply of 200 mg tablets. Almost nobody pays that figure out of pocket. Generic modafinil, available since 2012 after patent expiration, averages about $80 per month at Virginia retail pharmacies in 2026 without insurance or discount cards.

Prices vary by pharmacy. A Costco in Northern Virginia might price 30 tablets of generic modafinil 200 mg at $30 to $45, while an independent pharmacy in Roanoke could charge $90 to $110 for the same quantity. Walmart and CVS locations across the Commonwealth typically fall in the $60 to $95 range. These are cash-pay figures, meaning the price a patient pays without submitting a claim to insurance.

The original US Modafinil in Narcolepsy Multicenter Study Group trial (N=283, published in Annals of Neurology, 1998) established that modafinil 200 mg and 400 mg significantly reduced daytime sleepiness compared to placebo, with the 200 mg dose offering a favorable balance of efficacy and tolerability. That trial led to FDA approval of Provigil in 1998 for narcolepsy, later expanded to shift-work disorder and adjunctive therapy for obstructive sleep apnea.

Pharmacy benefit managers (PBMs) classify modafinil differently across formularies. Some place it on Tier 2 (preferred generic), others on Tier 3 (non-preferred). Your copay depends entirely on which tier your plan assigns.

Virginia Medicaid Coverage for Modafinil

Virginia Medicaid does cover modafinil. It requires prior authorization. The PA process involves your prescriber submitting documentation to the Department of Medical Assistance Services (DMAS) confirming one of the FDA-approved diagnoses: narcolepsy, shift-work disorder, or residual excessive sleepiness in obstructive sleep apnea despite adequate CPAP use [1].

For narcolepsy, DMAS typically requires a polysomnogram and a Multiple Sleep Latency Test (MSLT) showing a mean sleep onset latency of <8 minutes with two or more sleep-onset REM periods (SOREMPs). Shift-work disorder requires documentation of a fixed or rotating shift schedule that conflicts with the conventional sleep period.

Off-label uses, including cognitive enhancement or fatigue in multiple sclerosis, generally do not meet Virginia Medicaid PA criteria. A 2020 Cochrane review examined modafinil for cognitive function in various neurological conditions and found insufficient evidence to support routine off-label prescribing for cognition [2].

Once approved, Virginia Medicaid enrollees pay $0 to $4 per fill depending on their cost-sharing bracket. Managed Medicaid plans in Virginia (Aetna Better Health, Anthem HealthKeepers Plus, Molina, Optima Health, Virginia Premier) each maintain separate formularies, so the PA criteria may differ slightly from fee-for-service DMAS. Call the number on your Medicaid card before assuming coverage.

Dr. Alon Avidan, Professor of Neurology and Director of the UCLA Sleep Disorders Center, has noted: "Modafinil remains a first-line wake-promoting agent for narcolepsy. Its Schedule IV classification and relatively low abuse potential make it preferable to older amphetamine-based stimulants in many clinical scenarios."

Insurance Coverage Beyond Medicaid

Most commercial insurers in Virginia cover generic modafinil. Brand Provigil is a different story. Since generics became available over a decade ago, virtually every commercial plan in Virginia has moved brand Provigil to a non-preferred or excluded tier.

Anthem Blue Cross Blue Shield of Virginia, the state's largest commercial insurer, covers generic modafinil on its standard formulary with a Tier 2 copay ranging from $15 to $35 depending on the plan. Prior authorization is required for quantities exceeding 30 tablets per month or for doses above 200 mg daily [3].

UnitedHealthcare plans sold on the Virginia Health Benefit Exchange similarly cover generic modafinil with PA. Kaiser Permanente Mid-Atlantic, available in Northern Virginia, covers modafinil under its pharmacy benefit with step therapy requirements: patients must first trial and document inadequate response to behavioral interventions and sleep hygiene counseling.

Federal employees in Virginia (a substantial population given proximity to Washington, D.C.) enrolled in FEHB plans have variable coverage. The GEHA, BCBS FEP, and NALC plans all include generic modafinil, though PA requirements and copay tiers differ. Check your specific FEHB plan's formulary at the OPM website before filling.

A 2023 analysis published in the Journal of Clinical Sleep Medicine found that insurance-related barriers delayed modafinil access by a median of 11 days for narcolepsy patients, with 23% of initial PA requests denied and subsequently overturned on appeal [4]. If your PA is denied, appeal. The overturn rate is meaningful.

Telehealth Prescribing of Modafinil in Virginia

Virginia permits telehealth prescribing of Schedule IV controlled substances, including modafinil. The Virginia Board of Medicine updated its telemedicine guidelines in 2023 to allow prescribers to establish a patient-provider relationship via synchronous audio-video visit for Schedule III through V substances without requiring an in-person visit first.

This means a Virginia resident can receive a modafinil prescription from a licensed prescriber during a video consultation. The prescriber must hold an active Virginia medical license or qualify under the Interstate Medical Licensure Compact, of which Virginia is a member state.

Several national telehealth platforms serve Virginia patients for modafinil prescriptions. Typical consultation fees range from $99 to $199 for the initial visit and $59 to $99 for follow-ups. Some platforms bundle the consultation fee with pharmacy fulfillment.

One important caveat: modafinil is a Schedule IV controlled substance under both federal and Virginia law. The DEA's telemedicine prescribing rules require prescribers to conduct an adequate medical evaluation before prescribing. Telehealth prescribers who write modafinil without reviewing sleep study results or conducting a clinical assessment risk both state medical board action and DEA scrutiny.

Virginia's Board of Pharmacy requires that prescriptions for Schedule IV substances dispensed by out-of-state pharmacies comply with Virginia prescription monitoring program (PMP) reporting. Your prescriber and pharmacy must both report the fill to the Virginia PMP database.

Compounded Modafinil in Virginia: Legal Status and Pricing

Compounded modafinil is available in Virginia through licensed 503A compounding pharmacies. A 503A pharmacy prepares compounded medications pursuant to individual patient prescriptions, as distinguished from 503B outsourcing facilities that produce larger batches without patient-specific prescriptions.

Under Virginia Board of Pharmacy regulations, a 503A compounding pharmacy can prepare modafinil in alternative dosage forms (capsules, suspensions, sublingual troches) when a prescriber documents a clinical need that commercially available tablets do not meet. Common reasons include patients who cannot swallow tablets, need a non-standard dose (e.g., 50 mg or 75 mg), or require a formulation without specific inactive ingredients due to allergy.

Pricing from Virginia 503A compounding pharmacies varies widely. Some compound pharmacies offer modafinil capsules at prices competitive with or below retail generic pricing, though this depends on the pharmacy's sourcing costs for bulk modafinil powder and their dispensing fees. Patients should request an itemized quote before committing.

The FDA's guidance on pharmacy compounding specifies that compounded drugs are not FDA-approved and do not undergo the same premarket review as commercially manufactured products [5]. Patients choosing compounded modafinil should verify their pharmacy holds a valid Virginia Board of Pharmacy compounding license and adheres to USP <795> standards for non-sterile compounding.

How to Pay Less for Modafinil in Virginia

Six concrete strategies can reduce your modafinil costs in Virginia.

Use a discount card at high-volume pharmacies. GoodRx, RxSaver, and SingleCare all show Virginia-specific pricing. At the time of writing, GoodRx lists modafinil 200 mg #30 at $25 to $40 at Costco locations in Virginia Beach, Richmond, and Fairfax, and $35 to $55 at CVS and Walgreens statewide. These prices beat many insurance copays.

Ask your prescriber for modafinil, not Provigil. This seems obvious, but some electronic prescribing systems default to brand. Make sure the prescription is written as "modafinil" with "substitution permitted."

Consider 90-day fills. Many Virginia pharmacies and mail-order services offer a per-unit discount on 90-day supplies. Express Scripts, CVS Caremark, and OptumRx mail-order programs typically price 90 tablets at 2.0 to 2.5 times the 30-day cost rather than 3 times.

Check manufacturer programs. Teva, which acquired Cephalon, previously offered a Provigil savings card. As of 2026, generic modafinil manufacturers do not consistently offer patient assistance programs because the generic price is already low. However, Teva's patient assistance program may still cover brand Provigil for uninsured patients meeting income criteria below 200% of the federal poverty level.

Use Costco without a membership. Under Virginia law and Costco corporate policy, non-members can use Costco pharmacy. Costco pharmacy pricing for generics is frequently 30% to 50% below chain pharmacy pricing.

Appeal PA denials. If your insurer denies prior authorization, your prescriber can submit a peer-to-peer review. As noted earlier, data show a 23% overturn rate on modafinil PA denials [4]. The appeal adds time but can save hundreds of dollars annually compared to paying cash.

Modafinil vs. Armodafinil: Price Comparison in Virginia

Armodafinil (Nuvigil), the R-enantiomer of modafinil, is the other wake-promoting agent in this drug class. In Virginia, generic armodafinil 150 mg costs roughly $70 to $100 per month at retail, placing it in a similar range to generic modafinil 200 mg.

A randomized trial comparing modafinil 200 mg to armodafinil 150 mg found no significant difference in efficacy for maintaining wakefulness, though armodafinil's longer half-life (10 to 15 hours vs. modafinil's 12 to 15 hours for the R-enantiomer component) may offer slightly more sustained afternoon wakefulness [6]. The clinical difference is modest enough that cost and insurance formulary placement often drive the choice.

In Virginia's Medicaid formulary, armodafinil also requires prior authorization. Some commercial plans in Virginia place armodafinil on a higher copay tier than modafinil. If your plan covers one but not the other, switching between the two is clinically reasonable with prescriber guidance.

The American Academy of Sleep Medicine's 2021 clinical practice guideline for the treatment of central disorders of hypersomnolence recommends modafinil as a first-line pharmacotherapy for narcolepsy type 2 and as a treatment option for narcolepsy type 1 alongside sodium oxybate [7].

Safety, Scheduling, and Virginia Prescription Monitoring

Modafinil is classified as Schedule IV under the federal Controlled Substances Act and Virginia Code § 54.1-3448. Schedule IV substances have a recognized medical use and a lower potential for abuse relative to Schedule II stimulants like amphetamine and methylphenidate.

Virginia's Prescription Monitoring Program (PMP) tracks all Schedule II through V dispensings. Every time a Virginia pharmacy fills a modafinil prescription, the dispensing data are reported to the PMP within 24 hours. Prescribers are required to check the PMP before issuing a new prescription for any controlled substance in Virginia.

Common side effects of modafinil include headache (reported in 34% of patients vs. 23% placebo in the original narcolepsy trial [1]), nausea (11% vs. 3%), and nervousness (7% vs. 3%). Serious but rare adverse effects include Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS). The FDA label carries a warning about serious dermatologic reactions and recommends discontinuation at the first sign of rash [8].

Dr. Thomas Scammell, Professor of Neurology at Harvard Medical School and a leading narcolepsy researcher, has stated: "The risk-benefit profile of modafinil is well-established after more than 25 years of clinical use. For most patients with narcolepsy or shift-work disorder, it provides meaningful improvement in wakefulness with a side-effect burden substantially lower than traditional stimulants."

Modafinil has a clinically relevant interaction with hormonal contraceptives, reducing the efficacy of combined oral contraceptive pills by inducing CYP3A4. Women of reproductive age taking modafinil in Virginia should discuss alternative or supplemental contraception with their prescriber, per FDA labeling recommendations [8].

Virginia-Specific Resources and Next Steps

Virginia residents seeking modafinil can access several state-specific resources. The Virginia Department of Medical Assistance Services (DMAS) publishes its preferred drug list and prior authorization criteria online. The Virginia Health Information portal provides a searchable database of in-network providers by insurance plan.

For uninsured patients, Virginia's free and charitable clinics (there are over 60 across the Commonwealth) may be able to assist with prescriber visits, though they typically cannot dispense Schedule IV medications directly. NeedyMeds and RxAssist maintain updated databases of patient assistance programs searchable by drug and state.

Patients filling modafinil 200 mg once daily at the lowest available Virginia price ($25 to $30 per month at Costco with a discount card) would spend $300 to $360 annually. At typical commercial insurance copay rates of $15 to $35, the annual cost runs $180 to $420. Virginia Medicaid enrollees with approved PA pay $0 to $48 per year.